Our results strongly indicated that the increased expression of all 8 TRIM molecules in glioma tissues might play an important role in glioma, suggesting that these molecules may be potential diagnostic indicators and therapeutic targets for glioma patients and it is very promising for early screening of glioma patients in the future. This evidence concerns the gene TRAT1 and central nervous system cancer.